CONCLUSIONS	High Ki67-SI independently predicts for increased DSM , DM , and protocol BF in primarily intermediate-risk prostate cancer patients treated with RT with or without ADT on RTOG 94-08 but does not predict for local recurrence or for increased relative benefit from ADT .\